Skip to main content

Table 1 Baseline characteristics of participants included in CareRA (n = 379)

From: Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritis

  Distribution
Demographic variables
 Age, years 52 (13)
 BMI, kg/m2 26 (4)
 Women, n (%) 262 (69)
 Smokers, n smoked ever (%) 209 (55)
 RF positive, n (%) 252 (66)
 ACPA positive, n (%) 249 (66)
 Erosive disease, n (%) 97 (26)
 RDCI, mean (SD) 0.84 (1.15)
Clinical variables
 DAS28-CRP 4.8 (1.3)
 TJC28, median (IQR) 7 (8)
 SJC28 6 (8)
 PGA, mm (0–100) 55 (24)
 Pain, mm (0–100) 56 (24)
 Fatigue, mm (0–100) 48 (24)
 PhGA, mm (0–100) 52 (19)
 ESR, mm/h, median (IQR) 23 (30)
 CRP, mg/L, median (IQR) 21 (78)
 HAQ (0–3), median (IQR) 1 (1)
  1. Results are reported as mean (SD) unless otherwise specified. IQR interquartile range, BMI body mass index, RF rheumatoid factor, ACPA anti-citrullinated peptide antibody, RDCI Rheumatic Diseases Comorbidity Index, DAS28 Disease Activity Score in 28 joints, CRP C-reactive protein, TJC28 tender joint count in 28 joints, SJC28 swollen joint count in 28 joints, PGA patient’s global assessment of disease activity, PhGA physician’s global assessment of disease activity, ESR erythrocyte sedimentation rate, HAQ Health Assessment Questionnaire